Results 231 to 240 of about 121,342 (296)

Adults With Acid Sphingomyelinase Deficiency Have Sustained Improvements in Clinical Outcomes With up to 5 Years of Olipudase Alfa Enzyme Replacement Therapy: ASCEND Trial Final Results

open access: yesJournal of Inherited Metabolic Disease, Volume 49, Issue 3, May 2026.
ABSTRACT Acid sphingomyelinase deficiency (ASMD) is a rare debilitating lysosomal storage disease resulting in multisystemic disease manifestations, significant disease burden, and early mortality for some individuals. Enzyme replacement therapy (ERT) with olipudase alfa (Xenpozyme) is the first disease‐specific treatment indicated for noncentral ...
Melissa P. Wasserstein   +20 more
wiley   +1 more source

Erratum to “Abnormal Exercise Gas Exchange Before Pulmonary Emboli Diagnosis”

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes
doaj   +1 more source

Microscopic anatomy of the lungs of domestic animals, mice, and rats. [PDF]

open access: yesJ Vet Diagn Invest
Mulka KR   +3 more
europepmc   +1 more source

Dead space in critical care: a practical approach with clinical scenarios. [PDF]

open access: yesJ Anesth Analg Crit Care
Cipulli F   +7 more
europepmc   +1 more source

Beyond the PaO<sub>2</sub>/FiO<sub>2</sub> ratio: Rethinking ARDS severity through the Lens of physiology. [PDF]

open access: yesAnn Intensive Care
Al-Husinat L   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy